Physician profile
David Griffin
NPI 1770710261
$1,521.97
in general payments reported to CMS, 2019-2025
24 companies · $502 in 2025
The $502 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $120 · 2021: $18.17 · 2022: $336 · 2023: $280 · 2024: $266 · 2025: $502.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,013 · Education: $35.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,012.69 |
| Education | $35.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $194.78 | 2025 | Erleada |
| Astellas Pharma US INC | $194.53 | 2022-2025 | Xtandi, Myrbetriq |
| Dendreon Pharmaceuticals LLC | $145.01 | 2023-2025 | Provenge |
| Sumitomo Pharma America, INC. | $143.86 | 2023-2025 | Orgovyx, Gemtesa |
| Boston Scientific Corporation | $120.03 | 2022-2024 | Rezum Generator |
| Medtronic USA, INC. | $119.90 | 2020 | |
| Urovant Sciences INC | $87.00 | 2022 | |
| Pfizer INC. | $82.99 | 2025 | |
| Novartis Pharmaceuticals Corporation | $48.19 | 2024-2025 | |
| Tolmar, INC. | $46.22 | 2023 | |
| Axonics, INC. | $42.00 | 2023-2024 | Axonics |
| Astrazeneca Pharmaceuticals LP | $35.06 | 2025 | Imfinzi |
| Verity Pharmaceuticals INC. | $33.77 | 2024 | Trelstar |
| Endo USA, INC. | $29.48 | 2025 | Aveed, Xiaflex |
| Intuitive Surgical, INC. | $29.46 | 2023 | Da Vinci Surgical System |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Progenics Pharmaceuticals, INC. | $24.51 | 2024 | |
| Tolmar Pharmaceuticals, INC. | $23.65 | 2022 | |
| Urogen Pharma, INC. | $19.25 | 2024 | |
| Procept Biorobotics Corporation | $19.21 | 2023 | Aquabeam Robotic System |
| Bayer Healthcare Pharmaceuticals INC. | $18.71 | 2025 | |
| Medtronic, INC. | $18.17 | 2021 | |
| Telix Pharmaceuticals | $17.97 | 2024 | Illuccix |
| Endo Pharmaceuticals INC. | $16.40 | 2022 | |
| Antares Pharma, INC. | $11.82 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Griffin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.